Acridine-Based Chalcone 1C and ABC Transporters
Ondrej Franko, Martina Čižmáriková, Martin Kello, Radka Michalková, Olga Wesołowska, Kamila Środa-Pomianek, Sérgio M. Marques, David Bednář, Viktória Háziková, Tomáš Ján Liška, Viera Habalová

TL;DR
A new acridine-based chalcone, 1C, reduces multidrug resistance in colorectal cancer cells by inhibiting key ABC transporters and lowering galectin-1 expression.
Contribution
The study introduces 1C as a novel compound that selectively suppresses ABCB1 and ABCC1 proteins in colorectal cancer cells.
Findings
Compound 1C significantly reduced ABCB1 protein levels in COLO 320 cells at 24, 48, and 72 hours.
1C also lowered ABCC1 protein levels after 48 hours and galectin-1 expression in COLO 205 cells.
Molecular docking and ATPase tests suggest 1C acts as an allosteric modulator of ABCB1.
Abstract
Chalcones, potential anticancer agents, have shown promise in the suppression of multidrug resistance due to the inhibition of drug efflux driven by certain adenosine triphosphate (ATP)-binding cassette (ABC) transporters. The gene and protein expression of chosen ABC transporters (multidrug resistance protein 1, ABCB1; multidrug resistance-associated protein 1, ABCC1; and breast cancer resistance protein, ABCG2) in human colorectal cancer cells (COLO 205 and COLO 320, which overexpress active ABCB1) was mainly studied in this work under the influence of a novel synthetic acridine-based chalcone, 1C. While gene expression dropped just at 24 h, compound 1C selectively suppressed colorectal cancer cell growth and greatly lowered ABCB1 protein levels in COLO 320 cells at 24, 48, and 72 h. It also reduced ABCC1 protein levels after 48 h. Molecular docking and ATPase tests show that 1C…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer therapeutics and mechanisms · Synthesis and biological activity · Drug Transport and Resistance Mechanisms
